Company Overview
- Headquarters
- 7707 Gateway Blvd Suite 140, Newark CA
- Website
- protagonist-inc.com
- Phone
- (408) 649-7370
- Employees
- 130
- Founded in
- 2006
- Industry
- BioTech/Drugs
- Stock Symbol
- NASDAQ:PTG
- NAICS Code
-
NAICS Code 541714 CompaniesNAICS Code 5417 CompaniesNAICS Code 54 CompaniesNAICS Code 54171 CompaniesNAICS Code 541 Companies
- SIC Code
-
SIC Code 87 CompaniesSIC Code 873 Companies
Financials & Stats
Revenue
$47B
Total Funding Amount
$115M
Who is Protagonist Therapeutics Inc
Protagonist Therapeutics Inc. is a clinical-stage biopharmaceutical company headquartered in Newark, California. The company employs 130 people and generated $46.9 million in revenue. Protagonist Therapeutics focuses on discovering and developing peptide-based new chemical entities (NCEs) that aim to revolutionize treatments for diseases with significant unmet medical needs. Their technology platform allows them to create peptides with high potency, specificity, and selectivity, while also ensuring oral stability through specific peptidomimetic and chemical modifications. Their proprietary platform distinguishes them by enabling the discovery of peptides from scratch, ensuring they possess the desired qualities. This approach focuses on developing innovative peptide-based therapies for diseases with limited treatment options. For more information, visit protagonist-inc.com.
Company Leadership
Protagonist Therapeutics Inc Industry Tags
Protagonist Therapeutics Inc Tech Stack
Companies Similar to Protagonist Therapeutics Inc
Analyze industry trends and opportunities by examining competitors and companies comparable to Protagonist Therapeutics Inc, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 46M | 266 | Pleasanton, CA | 2015 | |
| 46M | 143 | Watertown, MA | 2016 | |
| 45M | 17 | Johannesburg, CA | 1997 | |
| 40M | 686 | Danvers, MA | 1999 | |
| 39M | 138 | Rockville, MD | 1999 |